Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Planned Initial Public Offering of Cortigent

Represented ThinkEquity, as underwriter, in connection with the planned IPO of Cortigent.

Loeb is representing ThinkEquity in all aspects of Cortigent’s IPO, including corporate, FDA regulatory, IP due diligence and other matters.